ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Sustained Drug Delivery in Interventional Glaucoma"
Episode Synopsis
I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started.
Editorially independent content supported with advertising by Glaukos.
Editorially independent content supported with advertising by Glaukos.
More episodes of the podcast GT: The Podcast
The Role of Anterior Segment OCT in MIGS
22/08/2025
A Cilioscleral Interpositioning Device
28/07/2025
Metabolic Dysfunction in Glaucoma
28/04/2025
In God we trust